Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ambiq Micro is a leading semiconductor company specializing in ultra-low-power microcontrollers and systems-on-chip (SoCs) for battery-powered edge devices. The company's proprietary Subthreshold Power Optimized Technology (SPOT) platform enables significant energy savings by operating transistors at subthreshold voltages, allowing for always-on artificial intelligence and extended battery life. Ambiq's products, including the Apollo and Atomiq SoC families, are widely integrated into clinical-grade health monitors, wearables, and IoT sensors to support real-time data processing. Headquartered in Austin, Texas, the company serves a global market across healthcare, consumer electronics, and industrial sectors. Ambiq went public on the New York Stock Exchange in 2025 under the symbol AMBQ.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ambiq Micro.